Certified by Founder Lodge
Adcendo
Denmark - Copenhagen, Capital Region of Denmark
START UP
1 Disclosed Funding Rounds $135,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need.
The company was founded in 2017 in Copenhagen, as a spin-out f
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 26 ,2024 | Series B | $135,000,000 |
Novo Holdings
Logos Capital
Surveyor Capital
TCGX
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
